Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1

Status

Completed 19Unknown 8Recruiting 8Terminated 4Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Genitourinary 8

Conditions

Breast Neoplasms 1841Neoplasms 1230Colorectal Neoplasms 1046Carcinoma, Non-Small-Cell Lung 996Stomach Neoplasms 787Carcinoma, Hepatocellular 780Lung Neoplasms 756Prostatic Neoplasms 682Pancreatic Neoplasms 567Rectal Neoplasms 444Colonic Neoplasms 401Neoplasm Metastasis 400Ovarian Neoplasms 399Uterine Cervical Neoplasms 395Recurrence 380Leukemia, Myeloid, Acute 367Esophageal Neoplasms 352Multiple Myeloma 340Lymphoma 330Head and Neck Neoplasms 326Melanoma 306Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Brain Neoplasms 263Urinary Bladder Neoplasms 249Nasopharyngeal Carcinoma 221Liver Neoplasms 221Leukemia 217Lymphoma, Large B-Cell, Diffuse 213Polycystic Ovary Syndrome 206Squamous Cell Carcinoma of Head and Neck 200

Interventions

talazoparib 1gallium 68 PSMA-11 1Radiosurgery 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Unknown × Prostate Cancer Metastatic × Clear all
NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Fudan University

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05627778 2022-11-28

68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis

Peking Union Medical College Hospital

Phase 1/2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05530395 2022-09-14

BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

University Hospital Virgen de las Nieves

Unknown
300 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05078151 2021-10-14

iPROMET

Vall d'Hebron Institute of Oncology

Phase NA Unknown
69 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04660617 2021-05-11

A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)

West China Hospital

Unknown
100 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Massachusetts General Hospital

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04603833 2021-02-21

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
150 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03414437 2019-03-19

Post-eRADicAte

Carolina Research Professionals, LLC

Unknown
31 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡